Filing Details

Accession Number:
0001209191-21-051446
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-13 17:22:45
Reporting Period:
2021-08-11
Accepted Time:
2021-08-13 17:22:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828443 Ortho Clinical Diagnostics Holdings Plc OCDX In Vitro & In Vivo Diagnostic Substances (2835) 981151819
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1839441 A. Michael Schlesinger C/O Ortho Clinical Diagnostics Holdings
1001 Route 202
Raritan NJ 08869
Evp, Gc And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, $0.00001 Par Value Acquisiton 2021-08-11 72,585 $6.28 160,222 No 4 M Direct
Ordinary Shares, $0.00001 Par Value Disposition 2021-08-11 72,585 $19.76 87,637 No 4 S Direct
Ordinary Shares, $0.00001 Par Value Acquisiton 2021-08-12 8,100 $6.28 95,737 No 4 M Direct
Ordinary Shares, $0.00001 Par Value Disposition 2021-08-12 8,100 $20.00 87,637 No 4 S Direct
Ordinary Shares, $0.00001 Par Value Acquisiton 2021-08-13 4,300 $6.28 91,937 No 4 M Direct
Ordinary Shares, $0.00001 Par Value Disposition 2021-08-13 4,300 $20.00 87,637 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares, $0.00001 Par Value Stock Option Disposition 2021-08-11 72,585 $0.00 72,585 $6.28
Ordinary Shares, $0.00001 Par Value Stock Option Disposition 2021-08-12 8,100 $0.00 8,100 $6.28
Ordinary Shares, $0.00001 Par Value Stock Option Disposition 2021-08-13 4,300 $0.00 4,300 $6.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
350,922 2024-10-22 No 4 M Direct
342,822 2024-10-22 No 4 M Direct
338,522 2024-10-22 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
  3. Represents the weighted average sales price for the price increments ranging from $19.4800 to $20.0700.
  4. Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0050.
  5. Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0100.
  6. The stock option is fully vested and exercisable.